Axogen, Inc. Appoints William Burke to Board of Directors

ALACHUA, Fla. and TAMPA, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that, effective July 11, 2022, William Burke has been appointed to its Board of Directors and will serve as chair of the Audit Committee. Mr. Burke is a recognized finance leader in the medical technology industry with more than 25 years of experience in senior leadership positions, including at Haemonetics, Medtronic, and Covidien. "Bill is an excellent addition to our board and brings a depth of finance, business development, and investor relations experience," commented Karen Zaderej, chairman, CEO, and president. "He has a long history of successful execution helping to bring forward medical solutions that improve patient outcomes and quality of life, which is fully aligned with the Axogen mission." Burke was the executive vice president, chief financial officer of Haemonetics Corporation from August 2016 to June 2022 with responsibility for the global finance organization including investor relations. From July 2014 to July 2016, Burke served as chief integration officer and vice president, Integration for Medtronic plc and was a member of its executive committee. In that role, he ... Full story available on Benzinga.com